2,4,5-trimethoxycinnamic acid: The major metabolite of α-asarone, retains most of the pharmacological properties of α-asarone

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 3, 2009, Pages 903-909

  Antunez Solis, Javier ^a   Hernández Derramadero, Fernando ^a   Aquino Vega, Mayda ^a   Ibarra Ramírez, Selene ^a   Rodríguez Páez, Lorena ^a   Baeza, Isabel ^a   Wong, Carlos ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

2,4,5 trimethoxycinnamic acid; A asarone; Bile flow; HMGCoA reductase; Hypocholesterolemic; Inhibition; Lipoproteins

Indexed keywords

2,4,5 TRIMETHOXYCINNAMIC ACID; ALPHA ASARONE; BILE SALT; CHOLESTEROL; CINNAMIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; UNCLASSIFIED DRUG; 2,4,5-TRIMETHOXYCINNAMIC ACID; ANISOLE DERIVATIVE; ANTILIPEMIC AGENT; ASARONE; BILE ACID; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; CHOLESTEROL BILE LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GALLBLADDER; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BILE; BLOOD; DRUG EFFECTS; METABOLISM; WISTAR RAT;

RATTUS;

ANIMALS; ANISOLES; ANTICHOLESTEREMIC AGENTS; BILE; BILE ACIDS AND SALTS; CHOLESTEROL; CINNAMATES; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS; MALE; PHOSPHOLIPIDS; RATS; RATS, WISTAR;

EID: 70749129733     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802318902     Document Type: Article

References (31)

1. Mart?́nez M. The medicial plants of Mexico 1967. p 125-127, 6- a ed. Ed. Botas. México
2. Mandoki JJ, Krumm-Heller C, Vega-Noverola J, Wong-Raḿrez C, Arriaga C, Roa R, Rubio C, Mendoza-Patino N. Isolation of a-asarone from the bark of Guatteria gaumeri (Elemuy) and the study of its hypocholesterolemic effect 1980., IV National Congress of Pharmacology, University of Yucatán, Mérida, Yucatán, México
3. Poplawski J, Lozowicka B, Dubis AT, Lachowska B, Witkowski S, Siluk D, Petrusewic J, Kaliszan R, Cybulski J, Strzalkowska M, Chilmoneczyk Z. Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo). J Med Chem 2000;43:3671-3676.
4. Rodriguez-Paez L, Juarez-SanchezM, Antunez-Solis J, Baeza I, Wong C. Alpha-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats. Phytomedicine 2003;10:397-404.
5. Howes AJ, Chan VS, Caldwell J. Structure-specificity of the genotoxicity of some naturally occurring alkenil benzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes. Food Chem Toxicol 1990;28:537-542.
6. Hasheminejad E, Caldwell J. Genotoxicity of the alkenylbenzenes alpha- and beta-asarone, myristicin and elimicin as determined by the UDS assay in cultured rat hepatocytes. Food Chem Toxicol 1994;32:223-231.
7. Wiseman RW, Miller EC, Miller JA, Liem A. Structure- activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J £ C3H/HeJ F1 mice. Cancer Res 1987;47:2275-2283.
8. Wilkinson GR. Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York: Mc Graw-Hill; 2001. p 12-16.
9. NIH. Guide for the care and use of laboratory animals Office of Sciences and Health Report DRR/NIH DHEW Publication 1985. p 85-123.
10. Turley SD, Dietschy JM. Re-evaluation of the 3-a-hidroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978;19:924-928.
11. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:998-1026.
12. Kleinsek A, Ranganathan S, Porter JW. Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver. Proc Natl Acad Sci U S A 1977;74:1431-1435.
13. Beg ZH, Stonik JA, Brewer HB. Purification and characterization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from chicken liver. FEBS Lett 1977;80:123-129.
14. Kim SJ, Bok SH, Lee MK, Park YB, Kim HJ, Choi MS. Lipidlowering efficacy of 3,4-di(OH)-phenylpropionic L-leucine in high-cholesterol fed rats. J Biochem Mol Toxicol 2005;19: 25-31.
15. Gleissner CA, Leitinger N, Ley K. Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension 2007;50:276-283.
16. Fruchart JC, Duriez P. Anti-cholesterol agents, new therapeutic approaches. Ann Pharm Fr 2004;62:3-18.
17. Istvan ES, Deisenhofer J. Structural mechanism for statin Inhibition of HMG-CoA reductase. Science 2001;29: 1160-1164.
18. Turley SD. Cholesterol metabolism and therapeutic targets, rationale for targeting multiple metabolic pathways. Clin Cardiol 2004;27:III16-III21.
19. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
20. Lusis AJ. Atherosclerosis. Nature 2000;407:233-241.
21. Clerc T, JomierM, Chautan M, Portugal H, Senft M, Pauli A, Laruelle C, Morel O, Lafont H, Chanussot F. Mechanism of action in the liver of crilvastatin, a new hydroxy-methylglutaryl- coenzyme A reductase inhibitor. Eur J Pharm 1993;235: 59-68.
22. Wierzbicki AS. Lipid-altering therapies and the progression of atherosclerotic disease. Cardiovasc Intervent Radiol 2007;30:155-160.
23. Roach PD, Balasubramaniam S, Hirata F, Abbey M, Szanto A, Simons LA, Nestel PJ. The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. Biochim Biophys Acta 1993;1170: 165-172.
24. Vlahcevic ZR, Heuman DM, Hylemon PB. Regulation of bile acid synthesis. Hepatology 1991;13:590-600.
25. Straka MS, Junker LH, Zacarro L, Zogg DR, Dueland S, Everson GT, Davis RAJ. Substrate stimulation of 7-alphahydroxylase, an enzyme located in the cholesterol-poor endoplasmic reticulum. J Biol Chem 1990;265:7145-7149.
26. JonesMP, PandakWM,HeumanDM, Chang JY,Hylemon PB, Vlahcevic ZR. Cholesterol 7-alpha-hydroxylase, evidence for transcriptional regulation by cholesterol or metabolic products of cholesterol in the rat. J Lipid Res 1992;34:385-392.
27. Carey CM, Small DM. The characteristics of mixed micellar solution with particular reference to bile. Am J Med 1970;49: 590-608.
28. Small DM. The formation of gallstones. Adv Intern Med 1970;16:243-264.
29. Smith OJ, Erkelens DW, Von Berger Henegorwen GP. Successful dissolution of cholesterol gallstones during treatment with pravastatin. Gastroenterology 1992;103:1068-1070.
30. Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JI. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972;286:1-8.
31. Gómez C, Chamorro G, ChávezMA, Mart?́nez G, Salazar M, Pages N. Effect of a-asarone on hypercholesterolemia and on experimental. cholelitiasis. Plant Med Phytother 1987;21: 279-284.